Remove 2028 Remove FDA Remove Hospitals
article thumbnail

Connected Medical Devices—the Next Target for Ransomware Attacks

Healthcare IT Today

Food and Drug Administration (FDA) has recognized the problem and issued multiple guidance documents over the years—as recently as this March —to ensure the cybersecurity of medical devices. Although none of the FDA recommendations are legally enforceable, device manufacturers no longer have a choice but to comply.

article thumbnail

A Whole New World for Laboratory Developed Tests – FDA Proposes End to Its Longstanding Policy of Enforcement Discretion

Hall Render

On September 29, 2023, the Food and Drug Administration (“FDA”) announced the issuance of a Notice of Proposed Rulemaking (the “Proposed Rule”) to expand the FDA’s regulatory scope over in vitro diagnostics products (“IVDs”) to specifically address Laboratory Developed Tests (“LDTs”).

FDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Connecting the Dots – Building Data Bridges for a Better Healthcare Future

HIT Consultant

For healthcare consumers, it provides a holistic and comprehensive medical history that is not specific to any healthcare organization or technology and that follows them wherever they go – at a hospital while on vacation, across town to a new provider, or at various specialists. It becomes a tangled web of data points.

article thumbnail

How Policy Changes Can Fix Market Distortions in Healthcare and Improve the Country’s Debt

Healthcare IT Today

A major justification for President Biden’s tax hike proposal is to shore up the tenuous finances of Medicare whose trust fund is forecasted to be depleted by 2028. Historically, it is the most prolific driver of family bankruptcy, and now it is on its way to bankrupting our country collectively.

Nurses 73
article thumbnail

SQA Regulatory Surveillance Summary for May and June 2024

SQA

Processes and Practices Applicable to Bioresearch Monitoring Inspections, Draft Guidelines for Industry, 04 June 2024 The FDA is announcing the availability of draft guidelines for industry entitled Processes and Practices Applicable to Bioresearch Monitoring Inspections. The deadline to submit feedback for this plan is 25 July 2024.

FDA 52
article thumbnail

Advances in Early Diagnosis

Healthcare IT Today

Currently, when hospitals monitor a patient being treated with vancomycin, they take a blood test that requires several hours to return results. Although the treatment regimen calls for testing once or twice a day at very specific times, many hospitals test less often due to workflow and resource constraints. This can save lives.

Doctors 117
article thumbnail

SQA Regulatory Surveillance Summary for May and June 2024

SQA

Processes and Practices Applicable to Bioresearch Monitoring Inspections, Draft Guidelines for Industry, 04 June 2024 The FDA is announcing the availability of draft guidelines for industry entitled Processes and Practices Applicable to Bioresearch Monitoring Inspections. The deadline to submit feedback for this plan is 25 July 2024.

FDA 40